Cart
sales@molnova.com
Sibirioside A
CAS No. 173046-19-0
Sibirioside A( ——— )
Catalog No. M38863 CAS No. 173046-19-0
Sibirioside A is a phenylpropanoid glycoside isolated fromScrophulariae Radix.Sibirioside A has the potential for the treatment of diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 308 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSibirioside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionSibirioside A is a phenylpropanoid glycoside isolated fromScrophulariae Radix.Sibirioside A has the potential for the treatment of diabetes.
-
DescriptionSibirioside A is a natural product
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number173046-19-0
-
Formula Weight472.44
-
Molecular FormulaC21H28O12
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang YF, et al. Investigation of the In Vivo Metabolism of Sibirioside A and Angoroside C in Rats by HPLC-ESI-IT-TOF-MSn.Molecules. 2018 Oct 19;23(10).?
molnova catalog
related products
-
Cixutumumab
Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling.
-
Adrenomedullin (AM) ...
Adrenomedullin (AM) (1-52), human (TFA) is an NH2 terminal truncated adrenomedullin analogue,affects cell proliferation and angiogenesis in cancer.
-
TriacetonaMine
Triacetonamine protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles.
